Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of dexmedetomidine and ketamine infusion on TMS-MEP and SSEP during spine surgery
IRCT20250507065634N11Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and ketamine in None (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Effect of dexmedetomidine vs ketamine on transcranial motor evoked potentials and Effect of dexmedetomidine vs ketamine on somatosensory evoked potentials. Started Dec 2025; status: completed.
02
Drugs
dexmedetomidineketamine
Beyond the preview
Go deeper on IRCT20250507065634N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250507065634N11.